June 2022 FDA Recall Testosterone Cypionate by Sun Pharmaceutical Industries Inc
D-1190-2022 - cGMP - Water leakage
This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on June 21, 2022 for the product Testosterone Cypionate. The FDA reported the reason for recall as cgmp - water leakage. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1190-2022
cGMP - Water leakage
06-21-2022
07-20-2022
50860 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
SUN PHARMACEUTICAL INDUSTRIES INC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
USA Nationwide
05-23-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Testosterone Cypionate Injection, USP, 200mg/mL, CIII, Rx only, 1mL Single-dose vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol- Baroda Highway, Halol-Baroda, Highway, Halol- 389 350, Gujarat, India, NDC 62756-015-40.
Batch or Lot Expiration Information
Lot# HAC4337A
